Targeting oxidative stress in diabetic kidney disease: a novel drug in an old pathway

This publication has 8 references indexed in Scilit:

• ASK1 contributes to fibrosis and dysfunction in models of kidney disease
  Journal of Clinical Investigation, 2018
• Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1
  Nature, 2018
• ASK1 facilitates tumor metastasis through phosphorylation of an ADP receptor P2Y12 in platelets
  Cell Death & Differentiation, 2017
• Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy
  Annals of Internal Medicine, 2016
• Design of a Phase 2 Clinical Trial of an ASK1 Inhibitor, GS-4997, in Patients with Diabetic Kidney Disease
  Nephron, 2014
• Molecular mechanisms of diabetic kidney disease
  Journal of Clinical Investigation, 2014
• Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
  New England Journal of Medicine, 2013
• Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinase
  Hepatology, 2011